Letter to Congress Regarding Legislation to Reauthorize the Medical Device User Fee Amendments
In a letter to the Committee on Energy & Commerce’s Subcommittee on Health in the U.S. House of Representatives, Public Citizen urged the subcommittee to consider including multiple provisions in legislation to reauthorize the Medical Device User Fee Amendments for fiscal years 2023 to 2027 (MDUFA V) that would significantly enhance the Food and Drug Administration’s regulatory oversight of medical devices, particularly high-risk, permanently implanted devices.